Looking at the daily chart, in the last month or so RXMD moved up rapidly along the upper Bollinger, and somewhat predictably as the RSI went into overbought, it cooled, consolidated, and bounced off the MA50 and lower Bollinger.

From here, it will most likely start moving north toward a reasonable valuation with renewed momentum, and presents a greater than 100% return in the short-term at current levels with an unknown ceiling as aggressive expansion efforts come to fruition.

Those who bought in the last day or so did well.